Abstract
Genotoxic stress-induced apoptosis is mediated by caspase family proteases as triggered by other stimuli. In this study, we found that the DNA-damaging agent cisplatin (cDDP) activated MAP kinase kinase kinase ASK1 and subsequent downstream subgroups of MAP kinase kinase, SEK1 (or MKK4) and MKK3/MKK6, which in turn activated c-Jun N-terminal kinase 1/stress-activated protein kinase (JNK1/SAPK) and p38 MAP kinase prior to caspase family protease activation and the onset of apoptosis in human ovarian carcinoma (OVCAR-3) and human kidney (293T) cells. As reported previously, benzyloxy carbonyl-Asp-CH2OC(O)-2, 6-dichlorobenzene (Z-Asp), a preferential inhibitor of caspase family proteases, blocked the apoptosis of OVCAR-3 cells induced by the genotoxic stress cDDP. Z-Asp, however, did not inhibit ASK1 activation and the subsequent kinase cascades. Overexpression of kinase-negative ASK1 (K709R), which inhibited ASK1 activation and the downstream MKK3-p38 and MKK4-JNK1 pathways, also suppressed the caspase protease activation and apoptosis induced by cDDP. These results indicate that the ASK1 pathway is involved in genotoxic stress-induced apoptosis and mediates apoptosis at a step upstream of caspase protease activation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Angel P and Karin M. . 1991 Biochim. Biophys. Acta 1072: 129–157.
Berberich I, Shu G, Siebelt F, Woodgett JR, Kyriakis JM and Clark EA. . 1996 EMBO J. 15: 92–101.
Bossy-Wetzel E, Bakiri L and Yaniv M. . 1997 EMBO J. 16: 1695–1709.
Brenner B, Koppenhoefer U, Weinstock C, Linderkamp O, Lang F and Gulbins E. . 1997 J. Biol. Chem. 272: 22173–22181.
Butterfield L, Storey B, Maas L and Heasley LE. . 1997 J. Biol. Chem. 272: 10110–10116.
Chen YR, Meyer CF and Tan TH. . 1996a J. Biol. Chem. 271: 631–634.
Chen YR, Wang X, Templeton D, Davis RJ and Tan TH. . 1996b J. Biol. Chem. 271: 31929–31936.
Chuang TH, Hahn KM, Lee JD, Danley DE and Bokoch GM. . 1997 Mol. Biol. Cell 8: 1687–1698.
Cobb MH and Goldsmith EJ. . 1995 J. Biol. Chem. 270: 14843–14846.
Colotta F, Polentarutti N, Sironi M and Mantovani A. . 1992 J. Biol. Chem. 267: 18278–18283.
Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL and Davis RJ. . 1997 Science 277: 693–696.
Dong J, Naito M and Tsuruo T. . 1997 Oncogene 15: 639–647.
Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. . 1992 Cell 69: 119–128.
Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E and Sanchez I. . 1997 Proc. Natl. Acad. Sci. USA 94: 3302–3307.
Graves JD, Draves KE, Craxton A, Saklatvala J, Krebs EG and Clark EA. . 1996 Proc. Natl. Acad. Sci. USA 93: 13814–13818.
Hunter T. . 1997 Cell 88: 333–346.
Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K and Gotoh Y. . 1997 Science 275: 90–94.
Karin M. . 1995 J. Biol. Chem. 270: 16483–16486.
Kaufmann SH. . 1989 Cancer Res. 49: 5870–5878.
Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE and Poirier GG. . 1993 Cancer Res. 53: 3976–3985.
Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y and Nishida E. . 1997 J. Biol. Chem. 272: 18518–18521.
Kerr JF, Wyllie AH and Currie AR. . 1972 Br. J. Cancer 26: 239–257.
Lenczowski JM, Dominguez L, Eder AM, King LB, Zacharchuk CM and Ashwell JD. . 1997 Mol. Cell. Biol. 17: 170–181.
Liu X, Kim CN, Yang J, Jemmerson R and Wang X. . 1996a Cell 86: 147–157.
Liu ZG, Hsu H, Goeddel DV and Karin M. . 1996b Cell 87: 565–576.
Martin SJ and Green DR. . 1995 Cell 82: 349–352.
Mashima T, Naito M, Kataoka S, Kawai H and Tsuruo T. . 1995 Biochem. Biophys. Res. Commun. 209: 907–915.
Meyn RE, Stephens LC, Hunter NR and Milas L. . 1994 Cancer Chemother. Pharmacol. 33: 410–414.
Meyn RE, Stephens LC, Hunter NR and Milas L. . 1995 Anticancer Drugs 6: 443–450.
Natoli G, Costanzo A, Ianni A, Templeton DJ, Woodgett JR, Balsano C and Levrero M. . 1997 Science 275: 200–203.
Nicholson DW and Thornberry NA. . 1997 Trends Biochem. Sci. 22: 299–307.
Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL and Miller DK. . 1995 Nature 376: 37–43.
Nishina H, Fischer KD, Radvanyi L, Shahinian A, Hakem R, Rubie EA, Bernstein A, Mak TW, Woodgett JR and Penninger JM. . 1997 Nature 385: 350–353.
Park DS, Stefanis L, Yan CYI, Farinelli SE and Greene LA. . 1996 J. Biol. Chem. 271: 21898–21905.
Potapova O, Haghighi A, Bost F, Liu C, Birrer MJ, Gjerset R and Mercola D. . 1997 J. Biol. Chem. 272: 14041–14044.
Sawai H, Okazaki T, Yamamoto H, Okano H, Takeda Y, Tashima M, Sawada H, Okuma M, Ishikura H and Umehara H. . 1995 J. Biol. Chem. 270: 27326–27331.
Searle J, Lawson TA, Abbott PJ, Harmon B and Kerr JF. . 1975 J. Pathol. 116: 129–138.
Seimiya H, Mashima T, Toho M and Tsuruo T. . 1997 J. Biol. Chem. 272: 4631–4636.
Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW and Greenberg AH. . 1994 Science 263: 1143–1145.
Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP and Green DR. . 1992 Science 257: 212–214.
Teng DH-F, Perry III WL, Hogan JK, Baumgard M, Bell R, Berry S, Davis T, Frank D, Frye C, Hattier T, Hu R, Jammulapati S, Janecki T, Leavitt A, Mitchell JT, Pero R, Sexton D, Schroeder M, Su P-H, Swedlund B, Kyriakis JM, Avruch J, Bartel P, Wong AKC, Oliphant A, Thomas A, Skolnick MH and Tavtigian SV. . 1997 Cancer Res. 57: 4177–4182.
Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM. . 1995 Cell 81: 801–809.
Thompson CB. . 1995 Science 267: 1456–1462.
Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z and Kolesnick RN. . 1996 Nature 380: 75–79.
Wyllie AH, Kerr JF and Currie AR. . 1980 Int. Rev. Cytol. 68: 251–306.
Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME. . 1995 Science 270: 1326–1331.
Yang D, Tournier C, Wysk M, Lu HT, Xu J, Davis RJ and Flavell RA. . 1997a Proc. Natl. Acad. Sci. USA 94: 3004–3009.
Yang X, Khosravi-Far R, Chang HY and Baltimore D. . 1997b Cell 89: 1067–1076.
Zanke BW, Boudreau K, Rubie E, Winnett E, Tibbles LA, Zon L, Kyriakis J, Liu FF and Woodgett JR. . 1996 Curr. Biol. 6: 606–613.
Acknowledgements
We thank Drs Hideki Nishitoh, Naoya Fujita, Koji Noguchi, Yongke Zhang and Akihiro Tomida for helpful discussions. This work was supported in part by a special grant for advanced research on cancer, grants-in-aid from the Ministry of Education, Science, Sports and Culture, Japan and the Organization for Pharmaceutical Safety and Research (OPSR), and the Vehicle Racing Commemorative Foundation, Japan.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, Z., Seimiya, H., Naito, M. et al. ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene 18, 173–180 (1999). https://doi.org/10.1038/sj.onc.1202276
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202276
Keywords
This article is cited by
-
Loss of the spectraplakin gene Short stop induces a DNA damage response in Drosophila epithelia
Scientific Reports (2020)
-
Co-expression of XIAP and CIAP1 Play Synergistic Effect on Patient’s Prognosis in Head and Neck Cancer
Pathology & Oncology Research (2019)
-
TGF-β downregulation-induced cancer cell death is finely regulated by the SAPK signaling cascade
Experimental & Molecular Medicine (2018)
-
Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells
Molecular Cancer (2013)
-
Arginine methylation-dependent regulation of ASK1 signaling by PRMT1
Cell Death & Differentiation (2012)